Evidence map›Paper›PMID 36847213›Full record

ArticleMolecular systems biology2023

Vibrio natriegens genome-scale modeling reveals insights into halophilic adaptations and resource allocation.

Lucas Coppens, Tanya Tschirhart, Dagmar H Leary, Sophie M Colston, Jaimee R Compton, William Judson Hervey, Karl L Dana, Gary J Vora, Sergio Bordel, Rodrigo Ledesma-Amaro

Abstract read
In one paragraph

Article in Molecular systems biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Metabolic engineering ofSynthetic and systems biotechnology · 2026
    Article
  2. Decoding the Hot-Mitochondrion Paradox.BioEssays : news and reviews in molecular, cellular and developmental biology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Vibrio natriegens: Application of a Fast-Growing Halophilic Bacterium.Advances in biochemical engineering/biotechnology · 2025
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Antibacterial and antibiofilm activity of halogenated phenylboronic acids againstFrontiers in cellular and infection microbiology · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lucas CoppensDepartment of Bioengineering and Imperial College Centre for Synthetic Biology, Imperial College London, London, UK.
Tanya TschirhartUS Naval Research Laboratory, Center for Bio/Molecular Science and Engineering, Washington, DC, USA.ORCID 0000-0003-2781-981X
Dagmar H LearyUS Naval Research Laboratory, Center for Bio/Molecular Science and Engineering, Washington, DC, USA.ORCID 0000-0003-2325-7143
Sophie M ColstonUS Naval Research Laboratory, Center for Bio/Molecular Science and Engineering, Washington, DC, USA.
Jaimee R ComptonUS Naval Research Laboratory, Center for Bio/Molecular Science and Engineering, Washington, DC, USA.ORCID 0000-0001-9476-4287
William Judson HerveyUS Naval Research Laboratory, Center for Bio/Molecular Science and Engineering, Washington, DC, USA.ORCID 0000-0003-3285-6754
Karl L DanaNOVA Research Inc, Alexandria, VA, USA.
Gary J VoraUS Naval Research Laboratory, Center for Bio/Molecular Science and Engineering, Washington, DC, USA.
Sergio BordelDepartment of Chemical Engineering and Environmental Technology, School of Industrial Engineering, University of Valladolid, Valladolid, Spain.
Rodrigo Ledesma-AmaroDepartment of Bioengineering and Imperial College Centre for Synthetic Biology, Imperial College London, London, UK.ORCID 0000-0003-2631-5898

Funding

Biotechnology and Biological Sciences Research Council BB/R01602X/1Biotechnology and Biological Sciences Research Council BB/T011408/1Biotechnology and Biological Sciences Research Council BB/T013176/1European Research Council DEUSBIO-949080European Research Council PERFECOAT-101022370
6 · The paper itself

Abstract

Vibrio natriegens is a Gram-negative bacterium with an exceptional growth rate that has the potential to become a standard biotechnological host for laboratory and industrial bioproduction. Despite this burgeoning interest, the current lack of organism-specific qualitative and quantitative computational tools has hampered the community's ability to rationally engineer this bacterium. In this study, we present the first genome-scale metabolic model (GSMM) of V. natriegens. The GSMM (iLC858) was developed using an automated draft assembly and extensive manual curation and was validated by comparing predicted yields, central metabolic fluxes, viable carbon substrates, and essential genes with empirical data. Mass spectrometry-based proteomics data confirmed the translation of at least 76% of the enzyme-encoding genes predicted to be expressed by the model during aerobic growth in a minimal medium. iLC858 was subsequently used to carry out a metabolic comparison between the model organism Escherichia coli and V. natriegens, leading to an analysis of the model architecture of V. natriegens' respiratory and ATP-generating system and the discovery of a role for a sodium-dependent oxaloacetate decarboxylase pump. The proteomics data were further used to investigate additional halophilic adaptations of V. natriegens. Finally, iLC858 was utilized to create a Resource Balance Analysis model to study the allocation of carbon resources. Taken together, the models presented provide useful computational tools to guide metabolic engineering efforts in V. natriegens.

Indexed as

VibrioCarbonResource AllocationCarbongenome-scale metabolic modelingmetabolic engineeringresource allocationsynthetic biologyVibrio natriegens

Identifiers

PMID36847213
PMCPMC10090949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.